Paper Review Records
全部论文审稿周期
22 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
375
天
CXCL12 + LSEC–CXCR4 + CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression
作者
Tomohiko Ikehara; Masaya Onishi; Takeo Toshima; Taro Tobo; Hiroko Oshima; Kiyotaka Hosoda; Takashi Ofuchi; Akinori Tsujimoto; Yu Takahashi; Koto Kawata; Shohei Shibuta; Yuki Ando; Qingjiang Hu; Yusuke Yonemura; Akira Shimizu; Hajime Otsu; Masanobu Oshima; Yutaka Suzuki; Takaaki Masuda; Yuka Fujimoto; Kiyoshi Hasegawa; Tomoharu Yoshizumi; Yuji Soejima; Koshi Mimori展开收起
作者单位
1. Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan; 2. Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan; 3. Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; 4. Department of Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 5. Department of Clinical Laboratory Medicine and Pathology, Kyushu University Beppu Hospital, Beppu, Oita, Japan; 6. Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; 7. Department of Breast and Endocrine Surgery, Kochi University, Kochi, Japan; 8. Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan展开收起
39
天
Clinicopathological and prognostic features of pancreatic acinar cell carcinoma: a nationwide multicenter study in Japan
作者
Atsushi Kanno; Noriyoshi Fukushima; Naohiro Sata; Kenji Notohara; Masamichi Hayashi; Takaaki Furukawa; Ryota Higuchi; Kosuke Okuwaki; Masayuki Ohtsuka; Toru Watanabe; Kazuhiko Shioji; Toshiya Abe; Hirohisa Kitagawa; Ryuta Muraki; Daisuke Hashimoto; Tomoyuki Satake; Junpei Yamaguchi; Namikatsu Takahara; Jun Nakahodo; Hiroaki Yasuda; Kazuichi Okazaki; Yoshifumi Takeyama; Hiroki Yamaue; Sohei Satoi; Atsushi Masamune展开收起
作者单位
1. Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan; 2. Department of Pathology, Division of Comprehensive Pathology, Jichi Medical University, Tochigi, Japan; 3. Department of Surgery, Division of Gastroenterological General and Transplant Surgery, Jichi Medical University, Tochigi, Japan; 4. Department of Anatomic Pathology, Kurashiki Central Hospital, Kurashiki, Japan; 5. Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; 6. Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; 7. Division of Gastroenterological Surgery, Tokyo Women’s Medical University, Yachiyo Medical Center, Yachiyo, Japan; 8. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, Japan; 9. Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan; 10. Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; 11. Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan; 12. Department of Gastroenterology, Niigata Cancer Center Hospital, Niigata, Japan; 13. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 14. Department of General Surgery, Kurashiki Central Hospital, Kurashiki, Japan; 15. Imaizumi Hospital, Toyama, Japan; 16. Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan; 17. Department of Gastroenterological Surgery, Shizuoka General Hospital, Shizuoka, Japan; 18. Department of Pancreatobiliary Surgery, Kansai Medical University, Hirakata, Japan; 19. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 20. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan; 21. Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan; 22. Department of Gastroenterology in Organ Pathophysiology Program, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 23. Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; 24. Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; 25. Department of Gastroenterology, Saiseikai Shiga Hospital, Shiga, Japan; 26. Department of Internal Medicine, Kansai Medical University, Kori Hospital, Neyagawa, Japan; 27. Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Japan; 28. Pancreatic Cancer Center, Department of HPB Surgery, Shonan Kamakura General Hospital, Kanagawa, Japan; 29. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan; 30. Department of Gastrointestinal Aging Control, Healthspan Research Center, Tohoku University, Sendai, Japan展开收起
36
天
62
天
Annualized fibrosis dynamics in metabolic dysfunction-associated steatotic liver disease: a paired-biopsy cohort
作者
Miwa Kawanaka; Kazuya Miyamoto; Shiho Murakami; Jinpeng Li; Ying Liu; Emi Tanaka; Nozomi Miyake; Takuya Adachi; Yasuto Takeuchi; Hideki Onishi; Ken Nishino; Takashi Fushimi; Noriyo Urata; Hirofumi Kawamoto; Motoyuki Otsuka展开收起
作者单位
1. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Okayama City, Japan; 2. Department of General Internal Medicine 2, Kawasaki Medical School, Okayama City, Japan展开收起
152
天
From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers
作者
Silvia Camera; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Christoph Gerdes; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Luisa Foltran; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Federico Rossari; Federica Lo Prinzi; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Lorenzo Fornaro; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Arndt Vogel; Gianluca Masi; Lorenza Rimassa; Andrea Casadei-Gardini展开收起
作者单位
1. IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy; 2. Vita-Salute San Raffaele University, Milan, Italy; 3. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 4. Department of Internal Medicine, Mayo Clinic, Phoenix, USA; 5. Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 6. Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; 7. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 8. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, Republic of Korea; 9. Oncology 1 Unit, Dept of Medical Oncology, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, Hannover, Germany; 11. Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy; 12. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 13. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 14. Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 15. Digestive Oncology, University Hospitals Leuven, Louvain, Belgium; 16. School of Cancer Sciences, Beatson West Of Scotland Centre, CRUK Scotland Centre, University of Glasgow, Glasgow, UK; 17. Department of Surgery&Cancer, Imperial College London, Hammersmith Hospital, London, UK; 18. Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; 19. Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, Tricase, Italy; 20. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; 21. Centro Di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano, Italy; 22. Santa Maria Delle Croci Hospital, AUSL, Ravenna, Italy; 23. Department DIMEC, University of Bologna, Bologna, Italy; 24. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain; 25. Department of Hematology, Oncology and Dermatology, UOC Oncologia A, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy; 26. Clinica Oncologica E Centro Regionale Di Genetica Oncologica, Università Politecnica Delle Marche, Azienda Ospedaliero-Universitaria Delle Marche, Ancona, Italy; 27. Digestive Unit, Champalimaud Clinical Centre, Champalimaud Research Centre, Lisbon, Portugal; 28. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea; 29. Department of Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; 30. HealthResearch Institute, Fundacion Jimenez Diaz University Hospital (IIS-FJD), Madrid, Spain; 31. Universidad Autonoma de Madrid (UAM), Madrid, Spain; 32. Medical Oncology and Biomedical Therapy, Policlinico Riuniti, Foggia, Italy; 33. Medical Clinic 1, University Hospital, Goethe-University Frankfurt, Frankfurt Am Main, Germany; 34. Dipartimento Di Oncologia Medica, Fondazione Poliambulanza, Brescia, Italy; 35. Clinical Experimental Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy; 36. IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy; 37. Internal Medicine 1, University Hospital Ulm, Ulm, Germany; 38. Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany; 39. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea; 40. Oncologia Medica, Dipartimento Di Medicina Dei Sistemi, Università Di Tor Vergata, Rome, Italy; 41. Department of Medical Oncology, Unidade Local de Saude Do Algarve (ULSAlg), Faro, Portugal; 42. Medical Oncology Unit, University Hospital of Parma, Parma, Italy; 43. Unit of Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 44. Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy; 45. Department of Oncology, University of Turin, San Luigi Hospital, Turin, Italy; 46. Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 47. Oncology Unit, Ospedale del Mare, Naples, Italy; 48. ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 49. Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy; 50. Oncology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy; 51. Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy; 52. GI Oncology Unit and Familial Cancer Unit, Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; 53. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, Italy; 54. Department of Medicine I, Clinical Division of Oncology, Medical University Vienna, Vienna, Austria; 55. Department of Medical Oncology, University Hospital of Udine, Udine, Italy; 56. UOC Oncologia Territoriale, ASL Latina, La Sapienza Università Di Rome, Polo Pontino, Latina, Italy; 57. National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 58. Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 59. Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; 60. Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 61. Department of Biomedical Sciences, Humanitas University, Milan, Italy; 62. Long Family Chair in Liver Cancer Research, Division of Gastroenterology and Hepatology, Medical Oncology, Princess Margaret Cancer Centre, Toronto General Hospital, Schwartz Reisman Liver Research Centre, Toronto, Canada展开收起
1
天
FAQ
JOURNAL OF GASTROENTEROLOGY审稿要多久?
截至2026-11-18,CrushSCI 收录了 JOURNAL OF GASTROENTEROLOGY 的 22 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(Defining progression timing before risk-adapted surveillance in Barrett’s esophagus,2026-08-11 收稿,2026-08-12 录用),最慢一篇用了 375 天;平均 92.0 天,中位数 73.5 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
